Thursday, July 14, 2016 4:17:37 PM
Do you have products or processes in the pipeline? When do you expect to come to market?
The transition from laboratory-scale production of cyclohexasilane to pilot-scale production is expected to occur within 12 months. The first product to be launched will be liquid cyclohexasilane (CHS). Based on market inquires we anticipate the first product will be used as an alternate to silane or trichlorosilane in silicon based semiconductor and solar cell manufacturing processes. Time to market is anticipated to be 1-2 years. We believe this first product will also be considered as an alternate to silicon particles, silicon nanowires, and silicon particle filled inks by the emerging printable electronics and LIB Si-anode industries. Time to market is anticipated to be 3-5 years. The purity of the first product has yet to be determined and will be based on the feedback of early adopters. We anticipate the first product to be released in the US market followed by Europe, Asia, and the UK.
Recent CRTG News
- Form SC 13D - General Statement of Acquisition of Beneficial Ownership • Edgar (US Regulatory) • 09/11/2024 12:42:46 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/11/2024 12:40:13 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 09/11/2024 12:39:43 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/09/2024 06:11:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/22/2024 06:32:29 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 06:21:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/05/2024 08:34:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/18/2024 01:30:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/08/2024 01:31:20 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/08/2024 01:30:18 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/06/2024 09:01:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 03:07:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 02:51:56 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/08/2023 06:06:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/31/2023 10:43:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/31/2023 10:41:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/31/2023 10:40:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/31/2023 10:38:33 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 10/31/2023 08:36:42 PM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM